Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis [Phase 4]
Phase 4 clinical trial update reporting completion of a conversion study evaluating switching from Hectorol Injection to Hectorol Capsules i…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients [Phase 3]
Phase 3 study completed comparing sevelamer carbonate powder with sevelamer hydrochloride tablets in haemodialysis patients with chronic kid…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis [Phase 3]
Phase 3 trial comparing Renagel (sevelamer) to calcium acetate for safety and efficacy in patients on peritoneal dialysis; the study has com…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Dialysis Clinical Outcomes Revisited (DCOR) Trial [Phase 4]
This clinical trial update reports on Phase 4 results from the Dialysis Clinical Outcomes Revisited (DCOR) trial. It examines outcomes assoc…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access [Phase 2, Phase 3]
A Phase 2/3 trial evaluating external ionizing radiation to prevent restenosis in hemodialysis vascular access has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Pruritus in Patients With Chronic Kidney Disease
A completed clinical trial investigating pruritus in patients with chronic kidney disease has posted results.
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Sympathetic Nerve Activity in Renal Failure [Phase 4]
A Phase 4 clinical trial examining sympathetic nerve activity in chronic kidney disease with hypertension has been withdrawn.
-
FDA label_change · 2015-03-16FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for FERAHEME (ferumoxytol) to update labeling. The changes may include revised indications, dosing, …
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: RenalGuard System and Contrast Media [Phase 3]
A Phase 3 trial update on the RenalGuard System used with contrast media in patients with Chronic Kidney Disease; study completed with resul…
-
CLINICAL_TRIALS withdrawal · 2015-03-09Clinical Trial Update: Optimal Treatment for Kidney Disease in HIV Infected Adults [Phase 3]
A Phase 3 clinical trial evaluating the optimal treatment for kidney disease in HIV-infected adults has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing [Phase 2]
A Phase 2 trial comparing once-daily sevelamer dosing with three-times-daily dosing in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) [Phase 3]
Phase 3 trial (EPPIC-1) evaluating AST-120 to prevent progression of chronic kidney disease has completed and posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) [Phase 3]
This clinical trial update reports completion of a Phase 3 study (EPPIC-2) evaluating whether AST-120 can prevent progression of chronic kid…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD [Phase 3]
A Phase 3 clinical trial evaluated a low-sodium peritoneal dialysis solution in hypertensive patients on peritoneal dialysis; the study has …
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Effect of Paricalcitol Over Vessel Wall [Phase 4]
Phase 4 trial evaluating the effect of paricalcitol on the vessel wall in nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis [Phase 4]
Phase 4 pharmacokinetic comparison of vitamin D2 vs D3 in stage 5 chronic kidney disease patients on chronic hemodialysis; the study has com…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Effect of Sevelamer on P-cresol Levels in CKD [Phase 3]
Phase 3 clinical trial evaluating whether sevelamer lowers p-cresol levels in adults with chronic kidney disease stages 3-5.
-
FDA approval · 2015-02-09FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution manufactured by Vantive US Hea…
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics [Phase 1]
This is a Phase 1 clinical trial update for rESP, evaluating tolerability, safety, and pharmacokinetics after a single intravenous dose with…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) [Phase 2, Phase 3]
Phase 2/Phase 3 trial of TRK-100STP for chronic kidney disease-related conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Study Comparing Dryweight Determination in Hemodialysis Patients With Two Methods [NA]
A completed clinical trial comparing two methods for determining dry weight in hemodialysis patients with chronic kidney disease.
-
FDA approval · 2015-01-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, resulting in an approved supplemental indication/lab…
-
CLINICAL_TRIALS research · 2015-01-22Clinical Trial Update: Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial [NA]
A completed clinical trial evaluating a decision aid to improve communication about anemia treatment risks for patients with chronic kidney …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients [Phase 1]
Phase 1 study completed evaluating the safety and pharmacokinetics of SK3530 tablets in male patients with renal impairment.
-
CLINICAL_TRIALS withdrawal · 2015-01-15Clinical Trial Update: A Phase 2 Extension of Study GCS-100-CS-4003 [Phase 2]
A Phase 2 extension study (GCS-100-CS-4003) for chronic kidney disease has been withdrawn.